Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	40.74	-37.66	26.76
Graham Fair Price	-53.12	2.01	4.29
PEG	25151.02	0.15	< 0.005
Price/Book	-5.00	0.68	0.71
Price/Cash Flow	-77.31	-60.56	266.92
Prices/Earnings	-320.51	-12.03	-2.86
Price/Sales	86.96	4.56	2.44
Price/FCF	-77.31	-60.56	266.92
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-49.05	0.11	0.22
Operating Margin	70.28	-0.06	-0.20
ROA	76.78	< 0.005	-0.04
ROE	-0.06	-0.01	77.41
ROIC	-0.06	-0.01	81.77
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.53	2.20	-75.88
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-14.69	0.85	-94.21
EPS QOQ	-46.92	0.78	-98.33
FCF QOQ	-0.80	-5.13	-539.36
Revenue QOQ	0.66	-0.50	-23.90
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	68.39	126.21	84.55
Days Sales Outstanding (DSO)	151.53	258.57	70.64
Inventory Turnover	1.32	0.71	-45.81
Debt/Capitalization	0.02	0.01	-51.85
Quick Ratio	1.57	1.61	2.54
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	3.62	3.57	-1.36
Cash	1.49	1.52	1.63
Capex	< 0.005	-0.01	-77.55
Free Cash Flow	< 0.005	-0.04	313.01
Revenue	1.06	0.53	-49.88
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.05	2.13	3.57
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-13.58	33.67	148.00
Naive Interpretation	Member

06 - Financial Health · Bad

Rating